Tarsus Pharmaceuticals
TARS61
$43.08arrow_drop_up0.20%$0.09
High Growth
TARS61
$43.08
arrow_drop_up0.20%| Key Stats | |
|---|---|
| Open | $42.90 |
| Prev. Close | $42.97 |
| EPS | -3.07 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 42.29 | 43.21 |
| 52 Week Range | 12.57 | 59.60 |
| Ratios | |
|---|---|
| EPS | -3.07 |
| Fundamentals | |
|---|---|
| Payout Ratio | - |
| Industry average yield | 2.89% |
| Last Dividend pay date | - |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
TARS-
US Healthcare Sector-
US Market-
check_circle
TARS / Market
TARS exceeded the US Market which returned 0.03% over the last twenty four hours.warning
TARS / Healthcare Sector
TARS lose to the US Healthcare sector which returned 2.60% over the last twenty four hours.Tarsus Pharmaceuticals (TARS) Statistics
Keep an eye on Tarsus Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is the EPS of Tarsus Pharmaceuticals (TARS) stock?
The Earnings Per Share (EPS) for Tarsus Pharmaceuticals (TARS), calculated on a diluted basis, is -$3.07. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
How has Tarsus Pharmaceuticals (TARS) stock's performance compared to its sector and the market over the past year?
Over the past year, Tarsus Pharmaceuticals (TARS) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 15.12%, Tarsus Pharmaceuticals has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 23.87%, it has fallen short of the market average. This comparison highlights Tarsus Pharmaceuticals 's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Tarsus Pharmaceuticals (TARS) stock?
The PE ratio for Tarsus Pharmaceuticals (TARS) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help
What is the operating margin of Tarsus Pharmaceuticals (TARS) stock?
The operating margin for Tarsus Pharmaceuticals (TARS) is -36.77%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Tarsus Pharmaceuticals (TARS) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Tarsus Pharmaceuticals (TARS) is -$119.34M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Tarsus Pharmaceuticals (TARS) have?
Tarsus Pharmaceuticals (TARS) has a total debt of $72.45M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$22.37M.